Breaking Finance News

A report released today by finnCap about Alliance Pharma PLC (LON:APH) keeps the target price at 58.00GBX

finnCap hold steady the price target of Alliance Pharma PLC (LON:APH) at 58.00GBX stating a possible upside of 0.10%.

Previously on 09/13/2017, Numis released a statement about Alliance Pharma PLC (LON:APH) held steady the target price at 60.00GBX that suggested an upside of 0.13%.

Only yesterday Alliance Pharma PLC (LON:APH) traded 0.48% higher at 52.75GBX. APH’s 50-day average is 52.79GBX and its two hundred day average is 50.55GBX. With the last stock price close up 3.85% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.04% over the same period. Trade Volume was down over the average, with 472,395 shares of APH changing hands under the typical 835,652

Performance Chart

Alliance Pharma PLC (LON:APH)

Alliance Pharma PLC has 52 week low of 41.33GBX and a 52 week high of 57.50GBX with a P/E ratio of 13.82 and has a market cap of 0 GBX.

A total of 1 equity analyst has released a research note on APH. 1 broker rating the stock a strong buy, 0 firms rating the stock a buy, 0 firms rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 analysts rating the company a sell with a one year target of 60.00GBX.

More About Alliance Pharma PLC (LON:APH)

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *